|
|
|
|
|
|
Identification and Characterization of Two Subpopulations of Encephalitozoon intestinalis. Rebecca M. Hoffman, 2003.Microsporidia are obligate intracellular protozoa that have been shown to be pathogenic to most living creatures . The development of in vitro cell culture propagation methods has provided researchers with large numbers of spores and facilitated the study of these organisms . Here, we describe heterogeneity within cell culture-propagated Encephalitozoon intestinalis suspensions . Flow cytometer histograms depicting the log side scatter and forward-angle light scatter of spores from nine suspensions produced over 12 months consistently showed two populations differing in size . The suspensions were composed primarily of the smaller-spore subpopulation (76.4% ± 5.1%) . The presence of two subpopulations was confirmed by microscopic examination and image analysis (P < 0.001) . Small subpopulation spores were noninfectious in rabbit kidney (RK13) cell culture infectivity assays, while the large spores were infectious when inocula included  25 spores . The small spores stained brilliantly with fluorescein isothiocyanate-conjugated monoclonal antibody against Encephalitozoon genus spore wall antigen, while the large spores stained poorly . There was no difference in staining intensities using commercial (MicroSporFA) and experimental polyclonal antibodies . Vital-dye (DAPI [4',6'-diamidino-2-phenylindole], propidium iodide, or SYTOX Green) staining showed the spores of the small subpopulation to be permeable to all vital dyes tested, while spores of the large subpopulation were not permeable in the absence of ethanol pretreatment . PCR using primers directed to the 16S rRNA or ß-tubulin genes and subsequent sequence analysis confirmed both subpopulations as E . intestinalis . Our data suggest that existing cell culture propagation methods produce two types of spores differing in infectivity, and the presence of these noninfective spores in purified spore suspensions should be considered when designing disinfection and drug treatment studies .
|
© 2005
Transgalactic Ltd (manufacturer of Bioscreen C software) |
Privacy Statement | P.O. Box
1393, 00101 Helsinki, Finland,
Last modified: May 25, 2005
| ||||||
